136 related articles for article (PubMed ID: 1370451)
1. Structural determinants for binary and ternary complex formation between insulin-like growth factor-I (IGF-I) and IGF binding protein-3.
Baxter RC; Bayne ML; Cascieri MA
J Biol Chem; 1992 Jan; 267(1):60-5. PubMed ID: 1370451
[TBL] [Abstract][Full Text] [Related]
2. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs.
Clemmons DR; Dehoff ML; Busby WH; Bayne ML; Cascieri MA
Endocrinology; 1992 Aug; 131(2):890-5. PubMed ID: 1379166
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
4. Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF)-binding protein-3 can form a 150-kilodalton binary complex in vitro in the absence of IGFs.
Lee CY; Rechler MM
Endocrinology; 1995 Nov; 136(11):4982-9. PubMed ID: 7588232
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit.
Twigg SM; Baxter RC
J Biol Chem; 1998 Mar; 273(11):6074-9. PubMed ID: 9497324
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the binding defect in insulin-like growth factor binding protein-3 from pregnancy serum.
Baxter RC; Suikkari AM; Martin JL
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):847-52. PubMed ID: 7691057
[TBL] [Abstract][Full Text] [Related]
7. The effect of GH therapy on the immunoreactive forms and distribution of IGFBP-3, IGF-I, the acid-labile subunit, and growth rate in GH-deficient children.
Mandel SH; Moreland E; Rosenfeld RG; Gargosky SE
Endocrine; 1997 Dec; 7(3):351-60. PubMed ID: 9657073
[TBL] [Abstract][Full Text] [Related]
8. Formation of 150-kDa binary complexes of insulin-like growth factor binding protein-3 and the acid-labile subunit in vitro and in vivo.
Lee CY; Rechler MM
Prog Growth Factor Res; 1995; 6(2-4):241-51. PubMed ID: 8817667
[TBL] [Abstract][Full Text] [Related]
9. Binding characteristics of pro-insulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6.
Bond JJ; Meka S; Baxter RC
J Endocrinol; 2000 May; 165(2):253-60. PubMed ID: 10810289
[TBL] [Abstract][Full Text] [Related]
10. The C region of human insulin-like growth factor (IGF) I is required for high affinity binding to the type 1 IGF receptor.
Bayne ML; Applebaum J; Underwood D; Chicchi GG; Green BG; Hayes NS; Cascieri MA
J Biol Chem; 1989 Jul; 264(19):11004-8. PubMed ID: 2472386
[TBL] [Abstract][Full Text] [Related]
11. Binding sites and binding properties of binary and ternary complexes of insulin-like growth factor-II (IGF-II), IGF-binding protein-3, and acid-labile subunit.
Hashimoto R; Ono M; Fujiwara H; Higashihashi N; Yoshida M; Enjoh-Kimura T; Sakano K
J Biol Chem; 1997 Oct; 272(44):27936-42. PubMed ID: 9346943
[TBL] [Abstract][Full Text] [Related]
12. A central domain binding site in insulin-like growth factor binding protein-5 for the acid-labile subunit.
Twigg SM; Kiefer MC; Zapf J; Baxter RC
Endocrinology; 2000 Jan; 141(1):454-7. PubMed ID: 10614670
[TBL] [Abstract][Full Text] [Related]
13. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex.
Bang P; Brismar K; Rosenfeld RG
J Clin Endocrinol Metab; 1994 May; 78(5):1119-27. PubMed ID: 7513716
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.
Sitar T; Popowicz GM; Siwanowicz I; Huber R; Holak TA
Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13028-33. PubMed ID: 16924115
[TBL] [Abstract][Full Text] [Related]
15. A major portion of the 150-kilodalton insulin-like growth factor-binding protein (IGFBP) complex in adult rat serum contains unoccupied, proteolytically nicked IGFBP-3 that binds IGF-II preferentially.
Lee CY; Rechler MM
Endocrinology; 1995 Feb; 136(2):668-78. PubMed ID: 7530649
[TBL] [Abstract][Full Text] [Related]
16. IGF binding proteins and their functions.
Clemmons DR
Mol Reprod Dev; 1993 Aug; 35(4):368-74; discussion 374-5. PubMed ID: 7691098
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma.
Lassarre C; Binoux M
Endocrinology; 1994 Mar; 134(3):1254-62. PubMed ID: 7509737
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain.
Twigg SM; Kiefer MC; Zapf J; Baxter RC
J Biol Chem; 1998 Oct; 273(44):28791-8. PubMed ID: 9786878
[TBL] [Abstract][Full Text] [Related]
19. The role of the acid-labile subunit in regulating insulin-like growth factor transport across human umbilical vein endothelial cell monolayers.
Payet LD; Firth SM; Baxter RC
J Clin Endocrinol Metab; 2004 May; 89(5):2382-9. PubMed ID: 15126567
[TBL] [Abstract][Full Text] [Related]
20. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
